Myasthenia Gravis Quality of Life 15-item Scale (MG-QoL15)

Burns TM; Cutter GR; Conaway M; Sanders DB


Basic description

Published in 2008.

Derived from the 60-item Myasthenia Gravis Quality Of Life (MG-QOL) questionnaire.

The authors recommended to use the revised version MG-QOL15r.


Burns TM; Cutter GR; Conaway M; Sanders DB

Muscle Study Group
Public domain (according to the author)
To measure Myasthenia Gravis (MG)-specific quality of life
Therapeutic area
  • Nervous System Diseases
  • Immune System Diseases
  • Rare disease (Orphanet definition)
Therapeutic indication

Myasthenia Gravis For more information on this rare disease, please consult the following link: Orphanet page

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
11 translation(s)
Bibliographic reference(s) of the original questionnaire

Burns TM, Conaway MR, Cutter GR, Sanders DB; Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve. 2008 Aug;38(2):957-63 (PubMed abstract)

Burns TM, Grouse CK, Conaway MR, Sanders DB; mg composite and mg-qol15 study group. Construct and concurrent validation of the MG-QOL15 in the practice setting. Muscle Nerve. 2010 Feb;41(2):219-26 (PubMed abstract)

Burns TM, Grouse CK, Wolfe GI, Conaway MR, Sanders DB; MG Composite and MG-OL15 Study Group. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve. 2011 Jan;43(1):14-8 (Pubmed Abstract)

Burns TM, Sadjadi R, Utsugisawa K, Gwathmey KG, Joshi A, Jones S, Bril V, Barnett C, Guptill JT, Sanders DB, Hobson-Webb L, Juel VC, Massey J, Gable KL, Silvestri NJ, Wolfe G, Cutter G, Nagane Y, Murai H, Masuda M, Farrugia ME, Carmichael C, Birnbaum S, Hogrel JY, Nafissi S, Fatehi F, Ou C, Liu W, Conaway M. International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r. Muscle Nerve. 2016 Dec;54(6):1015-1022 (Pubmed abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us